Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:investor
|
| gptkbp:focusesOn |
gptkb:biotechnology
life sciences |
| gptkbp:foundedBy |
GlaxoSmithKline
|
| gptkbp:foundedYear |
1985
|
| gptkbp:headquartersLocation |
gptkb:London,_United_Kingdom
gptkb:Redwood_City,_California |
| https://www.w3.org/2000/01/rdf-schema#label |
SR One
|
| gptkbp:industry |
venture capital
|
| gptkbp:investedIn |
early stage
growth stage |
| gptkbp:managingPartner |
gptkb:Simeon_George
|
| gptkbp:notableInvestment |
gptkb:Artios_Pharma
gptkb:CRISPR_Therapeutics gptkb:Nimbus_Therapeutics gptkb:Alector gptkb:Ribon_Therapeutics |
| gptkbp:operatesIn |
gptkb:United_Kingdom
gptkb:United_States |
| gptkbp:spinoutFrom |
GlaxoSmithKline
|
| gptkbp:website |
https://www.srone.com/
|
| gptkbp:bfsParent |
gptkb:Storm_Therapeutics
gptkb:HotSpot_Therapeutics gptkb:Nimbus_Therapeutics gptkb:Flare_Therapeutics |
| gptkbp:bfsLayer |
7
|